Women's hormone health

Hormone care for women is offered through both a structured  program and individual consultations.

The program is $1,400 and includes a physician-led initial assessment and three follow-up visits over 12 months for ongoing monitoring and treatment adjustment. Payment is required in full at booking.

Individual consultations are also available:

• Initial assessment: $600 (50% deposit required)
• 30-minute follow-up: $300 
• 15-minute follow-up: $150

Hormonal and metabolic conditions may present with significant symptoms even when standard laboratory results are within normal ranges. This is particularly common in perimenopause and PCOS, where hormone levels may fluctuate over time.

At Medalma, assessment is based on both clinical presentation and laboratory evaluation to better understand underlying hormonal function.

Perimenopause is the transitional phase leading up to menopause, during which ovarian hormone production becomes more variable and gradually declines. It can last several years and is often associated with changes in menstrual cycles and the onset of symptoms such as sleep disruption, mood changes, hot flashes, and changes in energy and cognitive function.

Perimenopause is diagnosed based on clinical symptoms and menstrual pattern changes rather than a single laboratory test.

Early signs of perimenopause may include irregular menstrual cycles, sleep disturbances, increased anxiety or mood changes, brain fog, fatigue, and changes in weight distribution or metabolic function. Some individuals may also notice worsening premenstrual symptoms or increased sensitivity to hormonal fluctuations.

Symptoms vary widely and may overlap with other hormonal, metabolic, or lifestyle-related factors.

Perimenopause is primarily diagnosed based on clinical symptoms and changes in menstrual patterns. Laboratory testing may be used to support clinical evaluation, but hormone levels can fluctuate significantly during this transition and may not always reflect symptom severity.

For this reason, diagnosis is based on a combination of clinical assessment and, when appropriate, targeted testing.

Polycystic ovary syndrome (PCOS) is a hormonal and metabolic condition characterized by a combination of ovarian dysfunction, androgen excess, and metabolic irregularities. It can affect menstrual regularity, skin and hair health, fertility, and insulin sensitivity.

PCOS presents differently between individuals and requires clinical evaluation for diagnosis.

Symptoms of PCOS may include irregular or absent menstrual cycles, acne, increased facial or body hair growth, scalp hair thinning, weight changes, and signs of insulin resistance. Some individuals may also experience fertility challenges or difficulty with metabolic regulation.

Not all symptoms are present in every case, and severity varies significantly.

PCOS management at Medalma is individualized and based on clinical evaluation of hormonal and metabolic contributors.

Care may include hormonal assessment and optimization when appropriate, metabolic support focused on insulin sensitivity, and targeted interventions for symptoms such as menstrual irregularity, skin changes, or hair loss.

Treatment is guided by ongoing clinical review and adjusted over time based on response.

Menopause is a natural biological stage in a woman’s life that marks the end of reproductive function. It typically occurs in three stages:

• Perimenopause – the transitional phase during which hormonal fluctuations begin and menstrual cycles become irregular, often accompanied by symptoms
• Menopause – defined as 12 consecutive months without a menstrual period, reflecting the end of ovarian function, though symptoms may persist
• Post-menopause – the phase following menopause, during which hormonal levels remain low and the body continues to adjust over time

Menopause is a normal physiological transition, though symptoms and their impact vary widely between individuals.

Menopause is a clinical stage defined by hormonal and menstrual changes, but symptoms can vary widely between individuals.

Common symptoms associated with the menopausal transition may include changes in menstrual cycles, brain fog, hot flashes, sleep disturbances, and mood changes.

At Medalma, clinicians use a comprehensive medical assessment, including clinical history and appropriate laboratory testing, to help determine where a patient may be in the menopausal transition and guide individualized care.

Menopause is associated with a decline in estrogen and progesterone levels, which can lead to a range of symptoms that vary between individuals.

Hormone therapy (HT) may be used in appropriate candidates to help relieve menopausal symptoms and improve quality of life by supplementing declining hormone levels.

At Medalma, hormone therapy is prescribed following a comprehensive medical assessment and is individualized based on each patient’s clinical profile, symptoms, and risk factors. Treatment options may include bioidentical hormone formulations when clinically appropriate.

Your treatment plan is individualized based on your symptoms, medical history, and clinical evaluation. When hormone therapy is appropriate, treatment may involve different hormonal or non-hormonal strategies depending on your clinical profile, underlying hormonal patterns, and treatment goals.

In some cases, additional therapies may be considered to support symptom management and address contributing hormonal or metabolic factors. All treatment decisions are made following a comprehensive assessment and are tailored to each patient’s individual needs and risk factors.

If you are currently on hormone therapy, the first step is a comprehensive medical assessment, including a review of your symptoms, medical history, and current treatment plan. Where appropriate, existing prescriptions and prior medical records may be reviewed to support continuity of care and guide any treatment adjustments.

Our clinicians will then determine the most appropriate next steps to transition your care safely and ensure your treatment remains clinically appropriate.